The aim of this study was to screen the presence of antimicrobial activities in the marine mollusc Thais tissoti and Babylonia spirata. In this study, the human bacterial pathogen Klebsiella pneumonia (10.02 ± 0.11 mm) and fungal pathogen Aspergillus niger (12.09 ± 0.06 mm) showed most sensitive to ethyl acetate extracts of T. tissoti. In B. spirata extracts, bacterial pathogen Proteus mirabilis (7.02 ± 0.04 mm) and fungal pathogen Candida albicans (8.13 ± 0.15* mm) exhibit high zone of inhibition against nbutanol extracts. Among the fish bacterial pathogens assayed, Aeromonas hydrophila (9.22 ± 0.03* mm) and fungal pathogen Ichthyophonus sp. (5.21 ± 0.11 mm) showed more sensitivity to n-butanol extract of T. tissoti. In B. spirata extracts, bacterial pathogen A. hydrophila (11.2 ± 0.6* mm) and fungal pathogens A. niger (15.12 ± 0.23* mm) showed most sensitive to n-butanol extracts. From biofilm bacteria, Micrococcus luteus (7.02 ± 0.11* mm), Micrococcus sp. (7.25 ± 0.03* mm) showed high sensitivity to n-butanol extracts of molluscs T. tissoti and B. spirata. These results signify that the marine mollusc extracts express remarkable antimicrobial activity against isolated microbes. The result strongly suggests that the molluscs extracts can be used as antimicrobial agents and further studies for purification and structural elucidation of antimicrobial drugs.
INTRODUCTION
The number of natural products isolated from marine organisms increases rapidly, and now exceeds with hundreds of new compounds being discovered every year (Faulkner, 2002; Proksch and Muller, 2006) . Modern technologies have opened vast areas of research for the extraction of biomedical compounds from ocean and seas to treat the deadly diseases. Many classes of natural products exhibiting antitumor, antileukemic, antibacterial and antiviral activities have been reported worldwide. Antimicrobial peptides are important in the *Corresponding author. E-mail: drpragathi@gmail.com. Tel: +91 4144 243223, Ext: 269 or +91 9894823364. Fax: +91 4144 243555. first line of the host defense system of many animal species. Marine invertebrates offer a source of potential antimicrobial drugs (Bazes et al., 2009) . There is much valuable information for new antibiotic discoveries and gives new insights into bioactive compounds in marine molluscs. Most marine molluscs are sessile soft bodies that inhabit benthic rock environments. A broad range of sessile marine organisms possess antifouling defences, suggesting that biofouling is an important selective pressure in the marine environment. Other selective pressures that could lead to the evolution of bioactive metabolites in the marine environment include predation and surface fouling. They either express constitutively or the expression is induced by exposure to pathogens. Contagious disease is a considerable problem to human health and in the agricultural industry. Disease in aquaculture is also predominantly caused by microbially mediated infections and this has lead to the widespread use of antibiotics overseas (Westra, 1998) . Of particular concern is the number of human pathogens that have developed multidrug resistance (Stinson, 1996) and some bacterial strains are resistant to all existing antibiotics (Setti and Micetich, 1998) . There is serious concern regarding new and reemerging infectious diseases for which no effective therapies are available (Cragg et al., 1997) . Prevention and control of these infectious bacteria will require the development of new antimicrobial agents. Generally fewer extensive, investigations have been made of the antimicrobial proteins of other invertebrate groups and although whole body homogenates of some marine invertebrates have been reported to contain a variety of antimicrobial compounds. Studies of antimicrobial compounds of marine invertebrates may provide valuable information for new antibiotic discoveries and give new insights into bioactive compounds in marine molluscs. The need for discovery of new and novel antibiotics is imperative because evidence suggests that development and spreading of resistance against any new antimicrobial agents is inevitable. The aim of this work was to investigate the antimicrobial effectors in different extracts of marine molluscs Thais tissoti and Babylonia spirata against isolated human, fish pathogens and primary biofilm microorganisms.
MATERIALS AND METHODS

Specimen collection and identification
The marine molluscs T. tissoti (Petit, 1852) and B. spirata (Linnaeus, 1758) were collected from Mudasalodai fishing harbour (Lat 11° 26' N; Long 79°46' E), Tamil Nadu, southeast coast of India. The collected fresh molluscs were preserved with ice and transported to the laboratory and identified by the standard literature of Fernando and Fernando (2002) and Gittenberger and Goud (2003) . The animals were carefully removed from the shells.
Extraction
The extraction method was followed by Chellaram et al. (2004) . The freshly collected mollusc tissues each 15 g in wet weight were soaked in methanol, acetone, chloroform, n-butanol, ethyl acetate and hexane and maintained for 3 days. The extracts were filtered through Whatman ® No.1 filter paper and the solvents were concentrated by rotary evaporator (VC100A Lark Rotavapor ® at 30°C) with reduced pressure to give a dark brown gummy mass. The resultant residues were stored at 4°C for further analysis.
Test microorganisms and microbial culture
Human bacterial and fungal pathogens
The reference pathogens used to test antimicrobial assay were, the following gram-positive and gram-negative bacteria such as, (Holt, 1994) and Manual of Clinical Microbiology (Mahony, 1999) . These Fish pathogenic bacterial strains and fungal strains were cultivated at 37°C and maintained on Zobell marine agar and fungal agar slants at 4°C.
Fouling organisms
The reference microbes were used to test antimicrobial assay, Micrococcus sp., S. aureus, Bacillus sp., Pseudomonas sp., Micrococcus luteus, Micrococcus sp.1, Proteus sp., Streptococcus sp.1, Streptococcus sp.2 and Klebsiella sp. The fouling bacteria used in the antibacterial assay were isolated from the biofilm formed over aluminium, fiber glass and Wood panels by pour plate method of Wahl (1995) and isolated strains were identified based on the morphological, cultural and biochemical characteristics following Bergey's Manual of Determinative Bacteriology (Holt, 1994) and Manual of Clinical Microbiology (Mahony, 1999) . These biofilm bacterial strains were cultivated at 37°C and maintained on Zobell marine agar slants at 4°C.
Antibacterial activity
Antibacterial activity was carried out by using standard disc diffusion method (Dulger and Gonuz, 2004; Parekh and Chanda, 2007; Laouer et al., 2009 ). The test cultures (bacteria 10 8 CFU/ml) were swabbed on top of the solidified media and allowed to dry for 10 min. The human bacteria were maintained on nutrient agar plates, fouling and fish pathogens maintained on Zobell marine agar plates. The different extracts of molluscs were applied on to 6 mm sterile discs in aliquots of 30 µl of solvent, allowed to dry at room temperature, and extract loaded discs were placed on agar plates seeded with isolated microorganisms and incubated at 37°C for 24 h. The susceptibility of the test organisms were determined by radius of the inhibition zone around each disc. All extracts were tested with triplicate at a concentration of 30 mg disc -1 .
Antifungal activity
Antifungal activity was carried out by using the standard disc diffusion method by (National Committee for Clinical Laboratory Standards, 2002) . The extracts applied to 6 mm sterile discs in aliquots of 30 µl of solvent, was allowed to dry at room temperature and placed on agar plates seeded with microorganisms. The cultures were maintained on fungal agar plates and incubated at 37°C for 24 h. Zones of growth inhibition were measured in millimeters after incubation. All the extracts were tested triplicate at a concentration of 30 mg disc -1 .
RESULT AND DISCUSSION
Marine organisms have been found to produce a great diversity of novel bioactive secondary metabolites potential source for new drug discovery. Extensive investigations of molluscs chemically and pharmacologically have been published in sufficient literature. A number of molluscs were ranked very high in the priority list of species exhibiting antimicrobial activity. The benthic invertebrates are potentially vulnerable to microbial infection, which may have led to the evolution of chemical defence mechanisms.
In the present investigation solvent extracts of both T. tissoti and B. spirata were concentrated under reduced pressure to give a dark brown gummy mass of 2.62 to 1.23 g, respectively. In this study a distinct antimicrobial activity has been observed against isolated bacterial and fungal strains. T. tissoti were mostly abundant in rocky shore but B. spirata mostly found in sandy shore. Through this study we have compared the antimicrobial activities of different benthic mollusc. In this experiment the solvents methanol, acetone, chloroform, n-butanol, ethyl acetate and hexane were used for extraction and these solvents were selected according to their polarity. The molluscs crude extracts were assayed against isolated human, fish pathogenic and biofilm microbes. From the antimicrobial assay methanol, n-butanol and chloroform extracts showed promising sensitivity against human pathogenic bacteria than fish pathogenic bacteria. The antibacterial activity of T. tissoti and B. spirata radius of the zone of inhibition around the disc were represented (Tables 1, 2 , 3, 4, 5 and 6). From the human pathogenic bacteria tested, K. pneumonia showed more sensitivity (10.02 ± 0.11 mm) against ethyl acetate extracts of T. tissoti and P. mirabilis showed more sensitivity (7.02 ± 0.04 mm) against n-butanol extract of B. spirata. From fish bacterial pathogenic microbes tested, A. hydrophila showed most sensitivity (9.22 ± 0.03* mm), (11.2 ± 0.6* mm) against both n-Butanol extracts. In the case of biofilm microbes, M. luteus (7.02 ± 0.11* mm), Micrococcus sp. (7.25 ± 0.03* mm) showed high sensitive to n-butanol extracts of T. tissoti and B. spirata. Antifungal activities were represented by the zone of inhibition around the disc. In human pathogenic fungal tested (Tables 7, 8 , 9 and 10), A. niger was the most sensitive (12.09 ± 0.06 mm) against ethyl acetate extracts of T. tissoti and C. albicans exhibited high zone (8.13 ± 0.15* mm) against n-butanol extracts of B. spirata. In fish pathogenic fungal tested, Ichthyophonus sp. showed more sensitivity (5.21 ± 0.11 mm) to nbutanol extract of T. tissoti and A. niger showed high zone (15.12 ± 0.23* mm) formation against n-Butanol extracts of B. spirata. These findings are consistent with previous studies on molluscs. Molluscan extracts produced the largest zones of inhibition out of all the marine extracts that were tested against E. coli and P. atrovenetum. Significantly, different species of mollusc were priority listed for activity in the different assays. Similar result was reported in four bivalves against few pathogens and found that extracts showed significant activity against Bacillus subtillus (Jayaseli et al., 2001 ). Likewise highest activity was observed against S. typhi in some gastropods (Prem et al., 1997) . The antibacterial activity of ethanol extract of gastropods Babylonia spirata and Turbo brunneus was observed maximum activity against E. coli, K. pneumoniae, P. vulgaris and S. typhi (Prem et al., 1997) . Very similar to this maximum antibacterial activity against S. aureus and E. coli on Trochus radiatus was reported (Mary et al., 2003a) . This study corroborates the results of the present investigation. Previous studies on the egg masses of marine gastropods, although few in number, have revealed striking contrasts in the biological activity of the species examined. On one hand, the gelatinous egg masses of molluscs in the Aplysiidae, exhibit a broad spectrum of biological activity (Pennings, 1994) . Several glycoproteins from the egg masses of Aplysia kurodai and Aplysia Juliana were found to have antimicrobial activity (Yamazaki, 1993) . Consequently, marine molluscs may have isolating compounds with specific activity against certain microorganisms or cell types. The benthic marine invertebrates could provide protection against infection, although his assertion does not appear to have ever been tested. However, several compounds with antibacterial activity have been isolated from the egg masses of some marine mollusks (Benkendorff et al., 2000a) . These investigations lend support to the present findings of the antimicrobial activity of T. tissoti and B. spirata. In the search for novel source of antibiotics it is appropriate to consider the circumstances under which antibiotics might be expected to evolve. Most species of invertebrates suffer disease from a wide range of microbial pathogens and parasites. Certain levels of immunity can be found in all living things. However, invertebrates lack many features of the vertebrate immune system (Beck and Habicht, 1996) and studies on invertebrate immunity have revealed some novel types of defence, such as antibacterial peptides and proteins (Hoffmann and Hetru, 1992) . On exposure to foreign material, some molluscs have been shown to exhibit a humoral defence response, including the release of bacteriostatic and bactericidal substances. Some of these molecules could have significant applications in medicine. Molluscs are widely used in world research institution for various studies, but only recently they have been recognized as potential sources of antibacterial and antifungal substances. The potential of marine mollusc as a source of biologically active products is largely unexplored. Hence, a broad based screening of marine molluscs for bioactive compounds is necessary. However, by far the majority of marine organisms are yet to be screened and the potential for discovering a useful antibiotic is sufficient to affirm further research.
Conclusion
From our result showed that the finding of novel bioactive compounds from marine molluscs by screening of different pathogenic microbes. This investigation was followed by the screening tactics based on the ecological knowledge of marine organisms being increasing deployed in the investigation of novel bioactive compounds. However, the result presented here indicated that marine molluscs show antimicrobial properties against human, fish pathogen and biofilm microbes. Our preliminary results reveal that many of these marine organisms produce more or less structurally diverse secondary metabolites which could be of Pharmaceutical interest.
